40

Journal of IiMER May 2025 She is leading the establishment of Austria’s first ME/CFS Biobank, designed to support future research and facilitate international collaboration. Her ongoing projects include investigations into the impact of mast cell activation, the differentiation between ME/CFS and depression, and the assessment of healthcare pathways for post-acute infection syndromes. Austria is becoming one of the most active research hubs for ME and we are delighted that Professor Untersmayr-Elsenhuber will present at IIMEC17 with details of the research landscape emerging in Austria and the practical steps being taken to improve care and scientific understanding of ME/CFS. Jos Bosch, University of Amsterdam, Netherlands IIMEC17 - Netherlands: A Foundational Strategy of Research for ME/CFS Jos Bosch is Associate Professor at the University of Amsterdam and a leading figure in the Netherlands’ national biomedical research strategy for ME/CFS. He coordinates the Dutch ME/CFS Cohort- and Biobank (NMCB) Consortium, a major initiative funded by a ZonMw grant of over seven million euros, which brings together all Dutch university medical centres, patient organisations, and the Ministry of Health to address fundamental questions about ME/CFS: its underlying mechanisms, improved diagnosis, and potential treatments. Under his leadership, the consortium is implementing harmonised research protocols that align with international standards, enabling direct comparison with large cohorts in the UK, Germany, and Canada. This approach is designed to accelerate progress and enhance the quality and impact of Dutch research. The consortium’s work is structured around three themes: outreach, relevance, and clinic, each with dedicated advisory input from patients. At IIMEC17, he will outlining the collaborative, patient-centred approach that is shaping the Dutch research landscape aimed at advancing understanding and care for people with ME/CFS. Etianne Martini Sasso, National Centre for Neuroimmunology and Emerging Diseases (NCNED), Australia IIMEC17 - Neurological and Immunological mechanisms underlying ME: an innovative and multidisciplinary investigation Etianne Martini Sasso will represent Professor Sonya MarshallGradisnik’s group at the National Centre for Neuroimmunology and Emerging Diseases (NCNED), Griffith University, Australia, and will speak on the neurological and immunological mechanisms underlying ME. The NCNED research team is recognised for its studies into ion channel dysfunction-particularly the TRPM3 ion channel-in ME and Long COVID. Etianne’s current research focuses on characterising TRPM3 ion channel function in natural killer (NK) cells using advanced patch-clamp Invest in ME Research Page 39 of 43

41 Publizr Home


You need flash player to view this online publication